VERU earnings: next report 2026-08-11, real EPS beat/miss history, analyst consensus Buy, P/E -2.82. Updated 2026-07-23.
Veru (VERU) Research Hub
Veru (VERU) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 2.44 USD (-1.61%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -2.82, market cap 0.04B. This hub links to the full technical, earnings and options research available for VERU.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 2.44 USD (-1.61%) |
| 52-week range | 2.16 USD – 3.28 USD |
| Trend regime | Range |
| 14-day RSI | 54.3 (Neutral) |
| Trailing P/E | -2.82 |
| Market cap | 0.04B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-11 |
Available research for VERU
Covered Call on VERU: how it works, illustrative setup around the real 2.44 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on VERU: how it works, illustrative setup around the real 2.44 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on VERU: how it works, illustrative setup around the real 2.44 USD price, max profit/loss, breakeven and when to use it. Educational.
VERU technical analysis: range, last 2.44 USD, RSI 54.3, 52w range 2.16 USD–3.28 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is VERU in?
Veru (VERU) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is VERU in an uptrend or downtrend?
As of 2026-09-11, VERU is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is VERU's trailing P/E ratio?
VERU's trailing P/E is -2.82, with a market cap of 0.04B. See the earnings research page for full valuation detail.
When does VERU next report earnings?
VERU is next scheduled to report earnings on 2026-08-11, with a consensus EPS estimate of -0.34 USD.